During the past decade, AIDS Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AIDS Care" #1 collaborator was "Pfizer" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AIDS Care" are "HIV Infections" (3 trials), "HIV" (2 trials), "Acquired Immunodeficiency Syndrome" (1 trials), "HIV, Combination Therapy" (1 trials) and "HIV-1" (1 trials). Many other conditions were trialed in "AIDS Care" in a lesser frequency.

Most popular intervention types in "AIDS Care" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "ATV" (2 trials), "ATV Placebo" (1 trials), "Atazanavir" (1 trials), "COBI" (1 trials) and "Cenicriviroc 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "AIDS Care" are 7 trials for "All" genders.

Currently, there are NaN active trials in "AIDS Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in AIDS Care, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in AIDS Care, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".